Literature DB >> 25689118

New Face for Chromatin-Related Mesenchymal Modulator: n-CHD9 Localizes to Nucleoli and Interacts With Ribosomal Genes.

Ronit Salomon-Kent1,2, Ronit Marom1,2, Sam John2, Miroslav Dundr2, Louis R Schiltz2, Jose Gutierrez3, Jerry Workman3, Dafna Benayahu1, Gordon L Hager2.   

Abstract

Mesenchymal stem cells' differentiation into several lineages is coordinated by a complex of transcription factors and co-regulators which bind to specific gene promoters. The Chromatin-Related Mesenchymal Modulator, CHD9 demonstrated in vitro its ability for remodeling activity to reposition nucleosomes in an ATP-dependent manner. Epigenetically, CHD9 binds with modified H3-(K9me2/3 and K27me3). Previously, we presented a role for CHD9 with RNA Polymerase II (Pol II)-dependent transcription of tissue specific genes. Far less is known about CHD9 function in RNA Polymerase I (Pol I) related transcription of the ribosomal locus that also drives specific cell fate. We here describe a new form, the nucleolar CHD9 (n-CHD9) that is dynamically associated with Pol I, fibrillarin, and upstream binding factor (UBF) in the nucleoli, as shown by imaging and molecular approaches. Inhibitors of transcription disorganized the nucleolar compartment of transcription sites where rDNA is actively transcribed. Collectively, these findings link n-CHD9 with RNA pol I transcription in fibrillar centers. Using chromatin immunoprecipitation (ChIP) and tilling arrays (ChIP- chip), we find an association of n-CHD9 with Pol I related to rRNA biogenesis. Our new findings support the role for CHD9 in chromatin regulation and association with rDNA genes, in addition to its already known function in transcription control of tissue specific genes.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25689118      PMCID: PMC6363339          DOI: 10.1002/jcp.24960

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma.

Authors:  Bo Guan; Xian-Gui Ran; Yong-Qiang Du; Feng Ren; Ye Tian; Ying Wang; Ming-Min Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  A Toxicogenomic Approach Reveals a Novel Gene Regulatory Network Active in In Vitro and In Vivo Models of Thyroid Carcinogenesis.

Authors:  Carla Reale; Filomena Russo; Sara Carmela Credendino; Danila Cuomo; Gabriella De Vita; Massimo Mallardo; Francesca Pennino; Immacolata Porreca; Maria Triassi; Mario De Felice; Concetta Ambrosino
Journal:  Int J Environ Res Public Health       Date:  2019-01-04       Impact factor: 3.390

3.  Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development.

Authors:  Andrej Alendar; Jan-Paul Lambooij; Rajith Bhaskaran; Cesare Lancini; Ji-Ying Song; Huub van Vugt; Margriet Snoek; Anton Berns
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

Review 4.  Translational control of stem cell function.

Authors:  James A Saba; Kifayathullah Liakath-Ali; Rachel Green; Fiona M Watt
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-16       Impact factor: 94.444

5.  Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.

Authors:  Li Xu; Hui Peng; Xiao-Xu Huang; Ya-Bin Xia; Kai-Feng Hu; Zheng-Ming Zhang
Journal:  Braz J Med Biol Res       Date:  2018-07-23       Impact factor: 2.590

6.  CHD9 upregulates RUNX2 and has a potential role in skeletal evolution.

Authors:  Axel H Newton; Andrew J Pask
Journal:  BMC Mol Cell Biol       Date:  2020-04-15

Review 7.  Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease.

Authors:  Andrej Alendar; Anton Berns
Journal:  Genes Dev       Date:  2021-11-01       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.